[1]
|
Jemal, A., Bray, F., Center, M.M., et al. (2011) Global Cancer Statistics. CA: A Cancer Journal for Clinicians, 61, 69-90. https://doi.org/10.3322/caac.20107
|
[2]
|
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A. and Jemal, A. (2018) Global Cancer Statistics: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. https://doi.org/10.3322/caac.21492
|
[3]
|
Lauby-Secretan, B., Scoccianti, C., Loomis, D., Benbrahim-Tallaa, L., Bouvard, V., Bianchini, F., Straif, K. and International Agency for Research on Cancer Handbook Working Group (2015) Breast-Cancer Screening—Viewpoint of the IARC Working Group. The New England Journal of Medicine, 372, 2353-2358.
https://doi.org/10.1056/NEJMsr1504363
|
[4]
|
Dafni, U., Grimani, I., Xyrafas, A., Eleftheraki, A.G. and Fountzilas, G. (2010) Fifteen-Year Trends in Metastatic Breast Cancer Survival in Greece. Breast Cancer Research and Treatment, 119, 621-631. https://doi.org/10.1007/s10549-009-0630-8
|
[5]
|
Barinoff, J., Heitz, F., Kuemmel, S., Dittmer, C., Hils, R., Lorenz-Salehi, F., Traut, A. and Bois, A. (2013) Improvement of Survival in Patient with Primary Metastatic Breast Cancer over a 10-Year Periode: Prospective Analyses Based on Individual Patient Date from a Multicenter Data Bank. Journal of Cancer Therapy, 4, 1306-1312.
https://doi.org/10.4236/jct.2013.48154
|
[6]
|
Kotsakis, A., Ardavanis, A., Koumakis, G., Samanthas, E., Psyrri, A. and Papadimitriou, C. (2019) Epidemiological Characteristics, Clinical Outcomes and Management Patterns of Metastatic Breast Cancer Patients in Routine Clinical Care Settings of Greece: Results from the EMERGE Multicenter Retrospective Chart Review Study.
BMC Cancer, 19, 88. https://doi.org/10.1186/s12885-019-5301-5
|
[7]
|
Dia, J., Saki, C., Mouhideen, O., Bohoussou, E., Touré, M., Okon, G., Guié, P. and Anongba, S. (2017) Epidemiological Aspects of Metastatic Relapse of Breast Cancer in an African Context. Open Journal of Obstetrics and Gynecology, 7, 552-561.
https://doi.org/10.4236/ojog.2017.75058
|
[8]
|
Smigal, C., Jemal, A., Ward, E., et al. (2006) Trends in Breast Cancer by Race and Ethnicity: Update 2006. CA: A Cancer Journal for Clinicians, 56, 168-183.
https://doi.org/10.3322/canjclin.56.3.168
|
[9]
|
Brewster, A.M., Hortobagi, G.N., Brogilo, K.R., et al. (2008) Residual Risk of Breast Cancer Recurrence 5 Years after Adjuvant Therapy. Journal of the National Cancer Institute, 100, 1179-1183. https://doi.org/10.1093/jnci/djn233
|
[10]
|
Schon, D., Bertz, J., Gorsch, B., Haberland, J. and Kurth, B.-M. (2004) Die Dachdokumentation Krebs. Gesundheitsbl-Gesundheitsforsch-Gesundheitsschutz, 47, 429-436.
https://doi.org/10.1007/s00103-004-0830-7
|
[11]
|
Surveillance Epidemiology and End Results Program (2005) 1973–2002. Division of Cancer Control and Population Science, National Cancer Institute.
https://seer.cancer.gov
|
[12]
|
Rugo, H.S., Majure, M., Dragun, A., Buxton, M. and Esserman, L. (2017) Neoplasms of Breast. In: Bast Jr., R.C., et al., Eds., Holland-Frei Cancer Medicine, 9th Edition, Wiley-Blackwell, Hoboken, NJ, 1368-1438.
|
[13]
|
Gnerlich, J., Jeffe, D.B., Deshpande, A.D., Beers, C., Zander, C. and Margenthaler, J.A. (2007) Surgical Removal of the Primary Tumor Increases Overal Survival in patients with Metastatic Breast Cancer: Analysis of the 1998-2003 SEER Data. Annals of Surgical Oncology, 14, 2187-2194.
https://doi.org/10.1245/s10434-007-9438-0
|
[14]
|
Lu, J., Steeg, P.S., Price, J.E., Krishnamurthy, S., Mani, S.A., Reuben, J., et al. (2009) Breast Cancer Metastasis: Challenges and Opportunities. Cancer Research, 69, 4951-4953. https://doi.org/10.1158/0008-5472.CAN-09-0099
|
[15]
|
Bonotto, M., Gerratana, L., Poletto, E., Driol, P., Giangreco, M., Russo, S., et al. (2014) Measures of Outcome in Metastatic Breast Cancer: Insights from a Real-World Scenario. Oncologist, 19, 608-615. https://doi.org/10.1634/theoncologist.2014-0002
|
[16]
|
Chevallier, B., Heintzman, F. and Mosseri, V. (1989) Quels sont les facteurs pronostics du cancer du sein opérable sans envahissement ganglionnaire axillaire histologique? Résultats d’une analyse uni et multifactorielle. Bulletin du Cancer, 76, 51-60.
|
[17]
|
De La Rochefordière, A., Asslain, B. and Campana, F. (1993) Age Prognostic Factor in Premenopausal Breast Carcinoma. The Lancet, 341, 1039-1043.
https://doi.org/10.1016/0140-6736(93)92407-K
|
[18]
|
Djanhan, L.E., Dia, J.M., Mian, B., Oyelade, M., Diallo, A., Guié, P. and Anongba, S. (2017) Occurrence Delays of Metastatic Relapses of Breast Cancers Treated at University Hospital of Treichville (Abidjan-Cote d’Ivoire). Journal of Cancer Therapy, 8, 924-932. https://doi.org/10.4236/jct.2017.811081
|
[19]
|
Toure, M., Nguessan, E., Bambara, A.T., Kouassi, Y.K.K., Dia, J.M.L. and Adoubi, I. (2013) Factors Linked to Late Diagnosis in Breast Cancer in Sub-Saharan Africa: Case of Cote D’Ivoire. Gynécologie Obstétrique et Fertilité, 41, 696-700.
https://doi.org/10.1016/j.gyobfe.2013.08.019
|
[20]
|
Korpela, J., Mali, P., Kaljonen, A. and Salminen, E. (2011) Quality of Life of Patients with Metastatic Breast Cancer Treated with Epirubicin and Docetaxel. International Journal of Clinical Medicine, 2, 346-351. https://doi.org/10.4236/ijcm.2011.23060
|
[21]
|
Rosen, P.P., Groshen, S., Kinne, D.W. and Norton, L. (1993) Factors Influencing Prognosis in Node Negative Breast Carcinoma: Analysis of 767 T1N0M0/T2N0M0 Patients with Long Term Follow-Up. Journal of Clinical Oncology, 11, 2090-2100.
https://doi.org/10.1200/JCO.1993.11.11.2090
|
[22]
|
Hanrahan, E.O., Gonzalez-Angulo, A.M., Giordano, S.H., et al. (2007) Overall Survival and Cause-Specific Mortality of Patients with Stage T1a,bN0M0 Breast Carcinoma. Journal of Clinical Oncology, 25, 4952-4960.
https://doi.org/10.1200/JCO.2006.08.0499
|
[23]
|
Nemoto, T., Vana, J., Bedwani, R.N., et al. (1980) Management and Survival of Female Breast Cancer: Results of a National Survey by the American College of Surgeons. Cancer, 45, 2917-2924.
https://doi.org/10.1002/1097-0142(19800615)45:12<2917::AID-CNCR2820451203> 3.0.CO;2-M
|
[24]
|
Hammoud, H., Saleh, J., Bachour, M. and Salamoon, M. (2014) Serum Caspase-3 and Caspase-7 as Predictive Factors of Response in Locally Advanced and Metastatic Breast Carcinoma. Journal of Cancer Therapy, 5, 584-590.
https://doi.org/10.4236/jct.2014.56067
|
[25]
|
Gogia, A., Deo, S.V.S., Sharma, D., Thulkar, S., Kumar, R., Malik, P.S. and Mathur, S. (2019) Clinicopathologic Characteristics and Treatment Outcomes of Patients with up-Front Metastatic Breast Cancer: Single-Center Experience in India. Journal of Global Oncology, 5, 1-9. https://doi.org/10.1200/JGO.18.00265
|
[26]
|
National Comprehensive Cancer Network (2016) NCCN Clinical Practice Guidelines in Oncology: Breast Cancer, Version 2. http://www.nccn.com
|
[27]
|
Cardoso, F., Costa, A., Senkus, E., Aapro, M., André, F., Barrios, C.H., et al. (2017) 3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3). Annals of Oncology, 28, 16-33.
|
[28]
|
Colombo, P.E., Milanezi, F., Weigelt, B. and Reis-Filho, J.S. (2011) Microarrays in the 2010s: The Contribution of Microarray-Based Gene Expression Profiling to Breast Cancer Classification, Prognostication and Prediction. Breast Cancer Research, 13, 212. https://doi.org/10.1186/bcr2890
|
[29]
|
Parise, C.A. and Caggiano, V. (2014) Breast Cancer Survival Defined by the ER/PR/HER2 Subtypes and a Surrogate Classification According to Tumor Grade and Immunohistochemical Biomarkers. Journal of Cancer Epidemiology, 2014, Article ID: 469251. https://doi.org/10.1155/2014/469251
|
[30]
|
Hess, K.R., et al. (2006) Metastatic Patterns in Adenocarcinoma. Cancer, 106, 1624-1633.
https://doi.org/10.1002/cncr.21778
|
[31]
|
Berman, A.T., Thukral, A.D., Hwang, W.T., Solin, L.J. and Vapiwala, N. (2013) Incidence and Patterns of Distant Metastases for Patients with Early-Stage Breast Cancer after Breast Conservation Treatment. Clinical Breast Cancer, 13, 88-94.
https://doi.org/10.1016/j.clbc.2012.11.001
|
[32]
|
Savci-Heijink, C.D., et al. (2015) Retrospective Analysis of Metastatic Behaviour of Breast Cancer Subtypes. Breast Cancer Research and Treatment, 150, 547-557.
https://doi.org/10.1007/s10549-015-3352-0
|
[33]
|
Gerratana, L., et al. (2015) Pattern of Metastasis and Outcome in Patients with Breast Cancer. Clinical & Experimental Metastasis, 32, 125-133.
https://doi.org/10.1007/s10585-015-9697-2
|
[34]
|
Wyld, L., et al. (2003) Prognostic Factors for Patients with Hepatic Metastases from Breast Cancer. British Journal of Cancer, 89, 284-290.
https://doi.org/10.1038/sj.bjc.6601038
|
[35]
|
Tarhan, M.O., et al. (2013) The Clinicopathological Evaluation of the Breast Cancer Patients with Brain Metastases: Predictors of Survival. Clinical & Experimental Metastasis, 30, 201-213. https://doi.org/10.1007/s10585-012-9528-7
|
[36]
|
Tseng, L.M., et al. (2013) Distant Metastasis in Triple-Negative Breast Cancer. Neoplasma, 60, 290-294. https://doi.org/10.4149/neo_2013_038
|
[37]
|
Liu, X.H., Man, Y.N., Cao, R., Liu, C. and Wu, X.Z. (2014) Individualized Chemotherapy Based on Organ Selectivity: A Retrospective Study of Vinorelbine and Capecitabine for Patients with Metastatic Breast Cancer. Current Medical Research and Opinion, 30, 1017-1024. https://doi.org/10.1185/03007995.2014.895310
|
[38]
|
Ahn, S.G., et al. (2013) Prognostic Factors for Patients with Bone-Only Metastasis in Breast Cancer. Yonsei Medical Journal, 54, 1168-1177.
https://doi.org/10.3349/ymj.2013.54.5.1168
|
[39]
|
Purushotham, A., et al. (2014) Age at Diagnosis and Distant Metastasis in Breast Cancer—A Surprising Inverse Relationship. European Journal of Cancer, 50, 1697-1705.
https://doi.org/10.1016/j.ejca.2014.04.002
|
[40]
|
Karimi, A., Delpisheh, A., Sayehmiri, K., Saboori, H. and Rahimi, E. (2014) Predictive Factors of Survival Time of Breast Cancer in Kurdistan Province of Iran between 2006-2014: A Cox Regression Approach. Asian Pacific Journal of Cancer Prevention, 15, 8483-8488. https://doi.org/10.7314/APJCP.2014.15.19.8483
|
[41]
|
Bourdeanu, L., Chen, L. and Luu, T. (2017) RetrospectiveReview for Prevalence and Survival in MetastaticBreast Cancer with Brain Metastasis in Two Patient Cohorts: One Collected 2000-2005 and the Second Collected 2006-2011. Journal of Cancer Therapy, 8, 490-505. https://doi.org/10.4236/jct.2017.85042
|
[42]
|
Niikura, N., Hayashi, N., Masuda, N., Takashima, S., Nakamura, R., Watanabe, K., et al. (2014) Treatment Outcomes and Prognostic Factors for Patients with Brain Metastases from Breast Cancer of Each Subtype: A Multicenter Retrospective Analysis. Breast Cancer Research and Treatment, 147, 103-112.
https://doi.org/10.1007/s10549-014-3090-8
|
[43]
|
Wadasadawala, T., Gupta, S., Bagul, V. and Patil, N. (2007) Brain Metastases from Breast Cancer: Management Approach. Journal of Cancer Research and Therapeutics, 3, 157-165. https://doi.org/10.4103/0973-1482.37409
|
[44]
|
Ushio, A., Sawaki, M., Fujia, T., Hattori, M., Kondo, N., Horio, A., Gondou, N., Iwata, H., et al. (2012) Clinicopathological Analysis of Breast Cancer Patients with Brain Metastases. Cancer Research, 72, P3-12-06-P3-12-06.
https://doi.org/10.1158/0008-5472.SABCS12-P3-12-06
|
[45]
|
Ghersi, D., Wilcken, N., Simes, J. and Donoghue, E. (2005) Taxane Containing Regimens for Metastatic Breast Cancer. Cochrane Database of Systematic Reviews, 2005, CD003366. https://doi.org/10.1002/14651858.CD003366.pub2
|